Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chuanhuang formula plus prostaglandin E1 for acute-on-chronic kidney injury
ChiCTR1800018411Phase 2Recruiting
- Sponsor
- Shanghai Municipal Hospital of Traditional Chinese Medicine
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of Vasostenoon and Chuan Huang Fang in acute kidney failure (AKF) and chronic kidney disease (CKD) (2 arms), sponsored by Shanghai Municipal Hospital of Traditional Chinese Medicine. Primary endpoints: serum creatinine, blood urea nitrogen and 4 more. Started Sep 2018; status: recruiting.
02
Drugs
VasostenoonChuan Huang Fang
03
Conditions
acute kidney failure (AKF)chronic kidney disease (CKD)
Beyond the preview
Go deeper on ChiCTR1800018411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018411.